866-997-4948(US-Canada Toll Free)

Europe Urology Drugs Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

Notes:
Sales, means the sales volume of Urology Drugs
Revenue, means the sales value of Urology Drugs

This report studies sales (consumption) of Urology Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Astellas
Endo
GP Pharm
Tolmar

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Urology Drugs in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
(alpha) - blockers
5 -reductase inhibitors

Split by application, this report focuses on sales, market share and growth rate of Urology Drugs in each application, can be divided into
Hospital
Clinic

Table of Contents

Europe Urology Drugs Market Report 2017
1 Urology Drugs Overview
1.1 Product Overview and Scope of Urology Drugs
1.2 Classification of Urology Drugs
1.2.1 (alpha) - blockers
1.2.2 5 -reductase inhibitors
1.3 Application of Urology Drugs
1.3.1 Hospital
1.3.2 Clinic
1.4 Urology Drugs Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Urology Drugs (2012-2022)
1.5.1 Europe Urology Drugs Sales and Growth Rate (2012-2022)
1.5.2 Europe Urology Drugs Revenue and Growth Rate (2012-2022)

2 Europe Urology Drugs by Manufacturers, Type and Application
2.1 Europe Urology Drugs Market Competition by Manufacturers
2.1.1 Europe Urology Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Urology Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Urology Drugs (Volume and Value) by Type
2.2.1 Europe Urology Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Europe Urology Drugs Revenue and Market Share by Type (2012-2017)
2.3 Europe Urology Drugs (Volume and Value) by Countries
2.3.1 Europe Urology Drugs Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Urology Drugs Revenue and Market Share by Countries (2012-2017)
2.4 Europe Urology Drugs (Volume) by Application

3 Germany Urology Drugs (Volume, Value and Sales Price)
3.1 Germany Urology Drugs Sales and Value (2012-2017)
3.1.1 Germany Urology Drugs Sales and Growth Rate (2012-2017)
3.1.2 Germany Urology Drugs Revenue and Growth Rate (2012-2017)
3.1.3 Germany Urology Drugs Sales Price Trend (2012-2017)
3.2 Germany Urology Drugs Sales and Market Share by Manufacturers
3.3 Germany Urology Drugs Sales and Market Share by Type
3.4 Germany Urology Drugs Sales and Market Share by Application

4 France Urology Drugs (Volume, Value and Sales Price)
4.1 France Urology Drugs Sales and Value (2012-2017)
4.1.1 France Urology Drugs Sales and Growth Rate (2012-2017)
4.1.2 France Urology Drugs Revenue and Growth Rate (2012-2017)
4.1.4 France Urology Drugs Sales Price Trend (2012-2017)
4.2 France Urology Drugs Sales and Market Share by Manufacturers
4.3 France Urology Drugs Sales and Market Share by Type
4.4 France Urology Drugs Sales and Market Share by Application

5 UK Urology Drugs (Volume, Value and Sales Price)
5.1 UK Urology Drugs Sales and Value (2012-2017)
5.1.1 UK Urology Drugs Sales and Growth Rate (2012-2017)
5.1.2 UK Urology Drugs Revenue and Growth Rate (2012-2017)
5.1.5 UK Urology Drugs Sales Price Trend (2012-2017)
5.2 UK Urology Drugs Sales and Market Share by Manufacturers
5.3 UK Urology Drugs Sales and Market Share by Type
5.4 UK Urology Drugs Sales and Market Share by Application

6 Russia Urology Drugs (Volume, Value and Sales Price)
6.1 Russia Urology Drugs Sales and Value (2012-2017)
6.1.1 Russia Urology Drugs Sales and Growth Rate (2012-2017)
6.1.2 Russia Urology Drugs Revenue and Growth Rate (2012-2017)
6.1.6 Russia Urology Drugs Sales Price Trend (2012-2017)
6.2 Russia Urology Drugs Sales and Market Share by Manufacturers
6.3 Russia Urology Drugs Sales and Market Share by Type
6.4 Russia Urology Drugs Sales and Market Share by Application

7 Italy Urology Drugs (Volume, Value and Sales Price)
7.1 Italy Urology Drugs Sales and Value (2012-2017)
7.1.1 Italy Urology Drugs Sales and Growth Rate (2012-2017)
7.1.2 Italy Urology Drugs Revenue and Growth Rate (2012-2017)
7.1.7 Italy Urology Drugs Sales Price Trend (2012-2017)
7.2 Italy Urology Drugs Sales and Market Share by Manufacturers
7.3 Italy Urology Drugs Sales and Market Share by Type
7.4 Italy Urology Drugs Sales and Market Share by Application

8 Spain Urology Drugs (Volume, Value and Sales Price)
8.1 Spain Urology Drugs Sales and Value (2012-2017)
8.1.1 Spain Urology Drugs Sales and Growth Rate (2012-2017)
8.1.2 Spain Urology Drugs Revenue and Growth Rate (2012-2017)
8.1.8 Spain Urology Drugs Sales Price Trend (2012-2017)
8.2 Spain Urology Drugs Sales and Market Share by Manufacturers
8.3 Spain Urology Drugs Sales and Market Share by Type
8.4 Spain Urology Drugs Sales and Market Share by Application

9 Benelux Urology Drugs (Volume, Value and Sales Price)
9.1 Benelux Urology Drugs Sales and Value (2012-2017)
9.1.1 Benelux Urology Drugs Sales and Growth Rate (2012-2017)
9.1.2 Benelux Urology Drugs Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Urology Drugs Sales Price Trend (2012-2017)
9.2 Benelux Urology Drugs Sales and Market Share by Manufacturers
9.3 Benelux Urology Drugs Sales and Market Share by Type
9.4 Benelux Urology Drugs Sales and Market Share by Application

10 Europe Urology Drugs Manufacturers Analysis
10.1 Astellas
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Urology Drugs Product Type, Application and Specification
10.1.2.1 (alpha) - blockers
10.1.2.2 5 -reductase inhibitors
10.1.3 Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Endo
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Urology Drugs Product Type, Application and Specification
10.2.2.1 (alpha) - blockers
10.2.2.2 5 -reductase inhibitors
10.2.3 Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 GP Pharm
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Urology Drugs Product Type, Application and Specification
10.3.2.1 (alpha) - blockers
10.3.2.2 5 -reductase inhibitors
10.3.3 GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Tolmar
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Urology Drugs Product Type, Application and Specification
10.4.2.1 (alpha) - blockers
10.4.2.2 5 -reductase inhibitors
10.4.3 Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview

11 Urology Drugs Manufacturing Cost Analysis
11.1 Urology Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Urology Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Urology Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Urology Drugs Market Forecast (2017-2022)
14.1 Germany Urology Drugs Sales Forecast (2017-2022)
14.2 France Urology Drugs Sales Forecast (2017-2022)
14.3 UK Urology Drugs Sales Forecast (2017-2022)
14.4 Russia Urology Drugs Sales Forecast (2017-2022)
14.5 Italy Urology Drugs Sales Forecast (2017-2022)
14.6 Spain Urology Drugs Sales Forecast (2017-2022)
14.7 Benelux Urology Drugs Sales Forecast (2017-2022)
14.8 Europe Urology Drugs Sales Forecast by Type (2017-2022)
14.9 Europe Urology Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Urology Drugs
Table Classification of Urology Drugs
Figure Europe Sales Market Share of Urology Drugs by Type in 2015
Figure (alpha) - blockers Picture
Figure 5 -reductase inhibitors Picture
Table Application of Urology Drugs
Figure Europe Sales Market Share of Urology Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Germany Urology Drugs Revenue and Growth Rate (2012-2022)
Figure France Urology Drugs Revenue and Growth Rate (2012-2022)
Figure UK Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Russia Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Italy Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Spain Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Benelux Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Urology Drugs Sales and Growth Rate (2012-2022)
Figure Europe Urology Drugs Revenue and Growth Rate (2012-2022)
Table Europe Urology Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Urology Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Urology Drugs Sales Share by Manufacturers
Figure 2016 Urology Drugs Sales Share by Manufacturers
Table Europe Urology Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Urology Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Urology Drugs Revenue Share by Manufacturers
Table 2016 Europe Urology Drugs Revenue Share by Manufacturers
Table Europe Urology Drugs Sales and Market Share by Type (2012-2017)
Table Europe Urology Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Urology Drugs by Type (2012-2017)
Figure Europe Urology Drugs Sales Growth Rate by Type (2012-2017)
Table Europe Urology Drugs Revenue and Market Share by Type (2012-2017)
Table Europe Urology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urology Drugs by Type (2012-2017)
Figure Europe Urology Drugs Revenue Growth Rate by Type (2012-2017)
Table Europe Urology Drugs Sales and Market Share by Countries (2012-2017)
Table Europe Urology Drugs Sales Share by Countries (2012-2017)
Figure Sales Market Share of Urology Drugs by Countries (2012-2017)
Table Europe Urology Drugs Revenue and Market Share by Countries (2012-2017)
Table Europe Urology Drugs Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Urology Drugs by Countries (2012-2017)
Table Europe Urology Drugs Sales and Market Share by Application (2012-2017)
Table Europe Urology Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Urology Drugs by Application (2012-2017)
Figure Germany Urology Drugs Sales and Growth Rate (2012-2017)
Figure Germany Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Germany Urology Drugs Sales Price Trend (2012-2017)
Table Germany Urology Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Urology Drugs Sales by Type (2015 and 2016)
Table Germany Urology Drugs Market Share by Type (2015 and 2016)
Table Germany Urology Drugs Sales by Application (2015 and 2016)
Table Germany Urology Drugs Market Share by Application (2015 and 2016)
Figure France Urology Drugs Sales and Growth Rate (2012-2017)
Figure France Urology Drugs Revenue and Growth Rate (2012-2017)
Figure France Urology Drugs Sales Price Trend (2012-2017)
Table France Urology Drugs Sales by Manufacturers (2015 and 2016)
Table France Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table France Urology Drugs Sales by Type (2015 and 2016)
Table France Urology Drugs Market Share by Type (2015 and 2016)
Table France Urology Drugs Sales by Application (2015 and 2016)
Table France Urology Drugs Market Share by Application (2015 and 2016)
Figure UK Urology Drugs Sales and Growth Rate (2012-2017)
Figure UK Urology Drugs Revenue and Growth Rate (2012-2017)
Figure UK Urology Drugs Sales Price Trend (2012-2017)
Table UK Urology Drugs Sales by Manufacturers (2015 and 2016)
Table UK Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Urology Drugs Sales by Type (2015 and 2016)
Table UK Urology Drugs Market Share by Type (2015 and 2016)
Table UK Urology Drugs Sales by Application (2015 and 2016)
Table UK Urology Drugs Market Share by Application (2015 and 2016)
Figure Russia Urology Drugs Sales and Growth Rate (2012-2017)
Figure Russia Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Russia Urology Drugs Sales Price Trend (2012-2017)
Table Russia Urology Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Urology Drugs Sales by Type (2015 and 2016)
Table Russia Urology Drugs Market Share by Type (2015 and 2016)
Table Russia Urology Drugs Sales by Application (2015 and 2016)
Table Russia Urology Drugs Market Share by Application (2015 and 2016)
Figure Italy Urology Drugs Sales and Growth Rate (2012-2017)
Figure Italy Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Italy Urology Drugs Sales Price Trend (2012-2017)
Table Italy Urology Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Urology Drugs Sales by Type (2015 and 2016)
Table Italy Urology Drugs Market Share by Type (2015 and 2016)
Table Italy Urology Drugs Sales by Application (2015 and 2016)
Table Italy Urology Drugs Market Share by Application (2015 and 2016)
Figure Spain Urology Drugs Sales and Growth Rate (2012-2017)
Figure Spain Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Spain Urology Drugs Sales Price Trend (2012-2017)
Table Spain Urology Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Urology Drugs Sales by Type (2015 and 2016)
Table Spain Urology Drugs Market Share by Type (2015 and 2016)
Table Spain Urology Drugs Sales by Application (2015 and 2016)
Table Spain Urology Drugs Market Share by Application (2015 and 2016)
Figure Benelux Urology Drugs Sales and Growth Rate (2012-2017)
Figure Benelux Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Benelux Urology Drugs Sales Price Trend (2012-2017)
Table Benelux Urology Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Urology Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Urology Drugs Sales by Type (2015 and 2016)
Table Benelux Urology Drugs Market Share by Type (2015 and 2016)
Table Benelux Urology Drugs Sales by Application (2015 and 2016)
Table Benelux Urology Drugs Market Share by Application (2015 and 2016)
Table Urology Drugs Basic Information List
Table Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Urology Drugs Sales Market Share (2012-2017)
Table Endo Basic Information List
Table Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Endo Urology Drugs Sales Market Share (2012-2017)
Table GP Pharm Basic Information List
Table GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GP Pharm Urology Drugs Sales Market Share (2012-2017)
Table Tolmar Basic Information List
Table Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Tolmar Urology Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urology Drugs
Figure Manufacturing Process Analysis of Urology Drugs
Figure Urology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
Table Major Buyers of Urology Drugs
Table Distributors/Traders List
Figure Germany Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Germany Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure France Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure France Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure UK Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure UK Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Russia Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Italy Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Spain Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Europe Urology Drugs Sales Forecast by Type (2017-2022)
Table Europe Urology Drugs Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *